← FDA Drug Approvals (Drugs@FDA)

RESERPINE AND HYDROFLUMETHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 1985-09-20

Drug application

FDA Application #
ANDA088907
Application type
Abbreviated New Drug Application (Generic)
Brand name
RESERPINE AND HYDROFLUMETHIAZIDE
Generic name
Hydroflumethiazide
Active ingredients
HYDROFLUMETHIAZIDE; RESERPINE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
PAR PHARM
First approval
1985-09-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown